NeuroPace, Inc.

NPCE· NASDAQ· Health Care· Health Care Equipment & Services

$12.26-5.76%

2026-10-30

Financials

Valuation Metrics

NeuroPace, Inc.'s Market Cap is $418M. At end of 2025 it was $505M. Ranked #2789 of 3,115 in US market (top 90%), #1226 of 1,469 on NASDAQ (top 83%), #176 of 203 in Health Care Equipment & Services (top 87%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$418M	US#2,789/3,115 Sec#176/203
Revenue	$99M	US#2,677/3,115 Sec#185/203
Net Income	$-19M	US—/3,115 Sec—/203
Total Assets	$97M	US#3,057/3,115 Sec#200/203
Net Assets	$12M	US#2,899/3,115 Sec#191/203
Value
P/B	35.18x	US#2,871/3,115 Sec#189/203
P/S	4.23x	US#2,205/3,115 Sec#145/203
FCF Yield	-2.78%	US—/3,115 Sec—/203
Profitability
ROE	-160.85%	US#2,824/3,115 Sec#185/203
ROA	-19.71%	US#2,786/3,115 Sec#176/203
Op. Margin	-15.26%	US#2,554/3,115 Sec#163/203
Revenue Growth	11.59%	US#1,118/3,115 Sec#77/203
Financial Health
Debt Ratio	716.22%	US#2,532/3,115 Sec#187/203
Total Debt	$70M	US#2,537/3,115 Sec#150/203
FCF	$-12M	US#2,381/3,115 Sec#154/203
Cash	$13M	US#2,939/3,115 Sec#198/203
Current Ratio	4.94x	US#478/3,115 Sec#39/203
Performance
1Y Return	24.34%	US#1,066/3,115 Sec#80/203
1M Return	-10.90%	US#2,424/3,115 Sec#178/203
From 52W High	-37.45%	US#2,115/3,115 Sec#152/203
1Y MDD	-36.55%	US#1,745/3,115 Sec#102/203
Trading
Volume	58,111 shares	US#3,010/3,115 Sec#199/203
Trading Value	$727549.00	US#3,041/3,115 Sec#192/203
Per Share
EPS	$-0.56	US—/3,115 Sec—/203
BPS	$0.35	US#2,770/3,115 Sec#192/203